Unverified50% confidenceFactExact time
Antibody design is an inverse problem: given a target structure, reverse-engineer an antibody sequence capable of binding to it.
1
Sources
50%
Confidence
Long-term
Relevance
9/21/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedCurrent mainstream AI antibody design methods include structure generation based on diffusion models (such as RFdiffusion), sequence generation based on language models (such as ESM and AntiBERTy), and hybrid architectures.72% similarUnverifiedThe application of artificial intelligence in protein structure prediction, target screening, and clinical trial design is compressing the drug development cycle.64% similarUnverified荷弹主张不应一上来就让AI写前端，而应先把后端结构想清楚再让AI生成前端55% similarUnverifiedAI models can directly predict ADMET properties based on molecular structure, thereby screening out candidates with poor druggability at an early stage.55% similarUnverifiedAlphaFold的蛋白质结构预测是定义清晰、有大量标注数据的预测问题，而AI科学家系统面对定义模糊的开放式科学问题，二者技术挑战级别存在根本差异54% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/939205API
curl https://kongchang.com/api/v1/knowledge/claims/939205MCP
get_claim(id=939205)